MeSH term
Count | Phosphodiesterase Inhibitors/diagnostic use | 3 |
Phosphodiesterase Inhibitors/*diagnostic use | 2 |
Phosphodiesterase Inhibitors | 3 |
*Phosphodiesterase Inhibitors | 1 |
Phosphodiesterase Inhibitors/chemistry | 2 |
Phosphodiesterase Inhibitors/*metabolism | 3 |
Phosphodiesterase Inhibitors/*pharmacokinetics | 2 |
Phosphodiesterase Inhibitors/urine | 1 |
Phosphodiesterase Inhibitors/pharmacology | 101 |
Phosphodiesterase Inhibitors/administration & | 1 |
Phosphodiesterase Inhibitors/blood | 1 |
Phosphodiesterase Inhibitors/*chemistry | 1 |
Phosphodiesterase Inhibitors/*pharmacology | 49 |
Phosphodiesterase Inhibitors/*therapeutic use | 12 |
Phosphodiesterase Inhibitors/therapeutic use | 7 |
Phosphodiesterase Inhibitors/immunology | 1 |
Phosphodiesterase Inhibitors/metabolism | 4 |
Sphingomyelin Phosphodiesterase/antagonists & inhibitors | 2 |
Phosphodiesterase Inhibitors/blood/urine | 1 |
*Phosphodiesterase Inhibitors/pharmacology/therapeutic use | 1 |
Phosphodiesterase Inhibitors/metabolism/*pharmacology | 1 |
Phosphodiesterase Inhibitors/metabolism/pharmacology | 1 |
Phosphodiesterase Inhibitors/classification/*pharmacology | 1 |
Phosphodiesterase Inhibitors/*analysis/pharmacology | 1 |
3',5'-Cyclic-GMP Phosphodiesterase/*antagonists & inhibitors | 3 |
Phosphodiesterase Inhibitors/*pharmacokinetics/urine | 1 |
Phosphodiesterase Inhibitors/administration & dosage | 1 |
Phosphodiesterase Inhibitors/pharmacokinetics/*pharmacology | 1 |
Phosphodiesterase Inhibitors/*metabolism/pharmacology | 1 |
Phosphodiesterase Inhibitors/*pharmacology/therapeutic use | 4 |
Phosphodiesterase Inhibitors/pharmacology/*therapeutic use | 3 |
Sphingomyelin Phosphodiesterase/*antagonists & inhibitors | 1 |
Phosphodiesterase Inhibitors/*chemistry/metabolism | 1 |
Phosphodiesterase Inhibitors/*administration & dosage | 1 |
Sphingomyelin Phosphodiesterase/antagonists & inhibitors/*metabolism | 2 |
Phosphodiesterase Inhibitors/chemistry/metabolism/pharmacology | 1 |
Phosphodiesterase Inhibitors/adverse effects/*therapeutic use | 1 |
Phosphodiesterase Inhibitors/*chemistry/*metabolism/pharmacology | 1 |
3',5'-Cyclic-Nucleotide Phosphodiesterase/*antagonists & inhibitors | 15 |
Sphingomyelin Phosphodiesterase/antagonists & inhibitors/metabolism | 1 |
Sphingomyelin Phosphodiesterase/*antagonists & inhibitors/metabolism | 2 |
Phosphodiesterase Inhibitors/blood/*pharmacokinetics/therapeutic use | 1 |
3',5'-Cyclic-GMP Phosphodiesterase/antagonists & inhibitors/*genetics | 1 |
3',5'-Cyclic-GMP Phosphodiesterase/antagonists & inhibitors/*metabolism | 2 |
Phosphodiesterase Inhibitors/administration & dosage/*therapeutic use | 1 |
3',5'-Cyclic-GMP Phosphodiesterase/*antagonists & inhibitors/genetics | 1 |
Sphingomyelin Phosphodiesterase/antagonists & inhibitors/*pharmacology | 1 |
Phosphodiesterase Inhibitors/*adverse effects/therapeutic use | 1 |
3',5'-Cyclic-Nucleotide Phosphodiesterase/antagonists & inhibitors | 8 |
Phosphodiesterase Inhibitors/*administration & dosage/adverse effects | 1 |
Phosphodiesterase Inhibitors/*chemical synthesis/chemistry/pharmacology | 1 |
3',5'-Cyclic-Nucleotide Phosphodiesterase/*antagonists & inhibitors/blood | 1 |
Phosphodiesterase Inhibitors/adverse effects/blood/metabolism | 1 |
Cholinesterase Inhibitors/diagnostic use | 1 |
Enzyme Inhibitors/*diagnostic use | 1 |
Enzyme Inhibitors/diagnostic use | 4 |
Protease Inhibitors/diagnostic use | 1 |
Growth Inhibitors/*blood/diagnostic use | 1 |
Apomorphine/antagonists & inhibitors/*diagnostic use | 1 |
Protein Synthesis Inhibitors/diagnostic use | 3 |
Protein Synthesis Inhibitors/*diagnostic use | 1 |
Enzyme Inhibitors/*diagnostic use/*pharmacology | 1 |
Cholinesterase Inhibitors/*diagnostic use/pharmacokinetics | 1 |
Oligopeptides/antagonists & inhibitors/diagnostic use | 1 |
Naloxone/antagonists & inhibitors/*diagnostic use | 1 |
Dopamine Uptake Inhibitors/diagnostic use | 1 |
Angiotensin-Converting Enzyme Inhibitors/*diagnostic use | 4 |
Chorionic Gonadotropin/antagonists & inhibitors/diagnostic use | 1 |
Factor Xa/*antagonists & inhibitors/diagnostic use/*metabolism | 1 |
Enzyme Inhibitors/*adverse effects/diagnostic use | 1 |
Angiotensin-Converting Enzyme Inhibitors/diagnostic use | 1 |
Cysteine Proteinase Inhibitors/*biosynthesis/diagnostic use/metabolism | 1 |
Angiotensin-Converting Enzyme Inhibitors/*diagnostic use/therapeutic use | 1 |
Angiotensin-Converting Enzyme Inhibitors/*diagnostic use/*pharmacology | 1 |
Serotonin Uptake Inhibitors/administration & dosage/*diagnostic use | 1 |
Angiotensin-Converting Enzyme Inhibitors/adverse effects/*diagnostic use | 1 |
Phosphodiesterase I | 2 |
*Sphingomyelin Phosphodiesterase | 1 |
*3',5'-Cyclic-GMP Phosphodiesterase | 1 |
Phosphodiesterase I/chemistry | 1 |
Phosphodiesterase I/metabolism | 1 |
*3',5'-Cyclic-Nucleotide Phosphodiesterase | 3 |
Sphingomyelin Phosphodiesterase/*deficiency | 2 |
Sphingomyelin Phosphodiesterase/*metabolism | 18 |
Sphingomyelin Phosphodiesterase/antagonists & | 1 |
Sphingomyelin Phosphodiesterase/chemistry | 1 |
3',5'-Cyclic-GMP Phosphodiesterase/analysis | 1 |
3',5'-Cyclic-GMP Phosphodiesterase/*biosynthesis | 3 |
Sphingomyelin Phosphodiesterase/pharmacology | 16 |
Sphingomyelin Phosphodiesterase/*biosynthesis | 1 |
Sphingomyelin Phosphodiesterase/*analysis | 1 |
Sphingomyelin Phosphodiesterase/*physiology | 2 |
Sphingomyelin Phosphodiesterase/physiology | 3 |
Sphingomyelin Phosphodiesterase/*genetics | 6 |
Sphingomyelin Phosphodiesterase/metabolism | 29 |
3',5'-Cyclic-GMP Phosphodiesterase/*chemistry | 1 |
3',5'-Cyclic-GMP Phosphodiesterase/metabolism | 4 |
3',5'-Cyclic-GMP Phosphodiesterase/*analysis | 1 |
3',5'-Cyclic-GMP Phosphodiesterase/*genetics | 16 |
3',5'-Cyclic-GMP Phosphodiesterase/genetics | 4 |
